CClinicalTrials.gg
RecruitingNCT05610124Updated Jun 26, 2023

Postprandial Glycemia and Satiety of Meals With Potatoes, With and Without Protein

An interventional study of Ad libitum full-fat French fries with beef meatballs and Ad libitum instant mashed potatoes with beef meatballs in Glycemic Control, Satiety Response and Appetite Regulation, sponsored by University of Toronto. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-26.

Sponsored by University of Toronto · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 9 months ago, but the record still lists the study as recruiting.
  • Started Feb 2023; still recruiting 3 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The proposed study aims to simulate a meal eaten at home, where meals will provide a fixed amount of protein from beef or vegetarian substitute "meat" balls with ad libitum access to one of mashed potatoes, full-fat fries, or pasta. Postprandial glycemia (PPG), insulin, active ghrelin, satiety, amino acid response and food intake (FI) at the meal and again 3h later (after an ad libitum pizza meal) will be measured. In addition, post-meal PPG and satiety will be measured for one hour after the second meal.

Read the detailed description

A total of 30 participants (15 males, 15 females) will be recruited in this study at the University of Toronto. Each participant will attend 6 study sessions where they will consume meals consisting of a fixed amount of beef or vegetarian substitute "meat" balls providing 25 g protein with ad libitum access to one of mashed potatoes, fried French fries, or pasta. Questionnaires will be filled out to assess their recent food intake, physical activity, sleep quality, stress level, appetite, physical comfort, and energy/fatigue level, as well as palatability of the food.

Blood samples will be collected at fasting and at various time points over a 3 hour period after eating the meals to measure blood glucose, insulin, active ghrelin and amino acid concentrations. After 3 hours, participants will receive an ad libitum pizza meal to assess their food intake compensation. Post-meal PPG and satiety will be measured for one hour after the pizza meal.

Study hypothesis:

  1. Consumption of potatoes in their most usual forms (mashed or deep fried), when compared with pasta in either meat or vegetarian based meals result in lower FI at the meal and lower PPG and insulin.
  2. Compensation for the reduced FI in the mashed potato meal does not occur at a pizza meal 3h later.
  3. Lower PPG and insulin post-test meal and second meal will be found.
  4. The amino acid profile of different meals will be reflected in post-prandial plasma levels and the amino acid response to vegetarian based meals with potatoes will be more balanced compared to the vegetarian based meals with pasta.

Primary objective:

To investigate the effects of potato consumption served with either meat or vegetarian substitute "meat" on meal-time FI and PPG, insulin, satiety and FI compensation at a later meal in healthy and normal weight adults. FI and PPG are primary outcomes and satiety, insulin, active ghrelin, amino acid response and FI compensation are secondary outcomes.

Specific Objectives:

Objective 1: To simulate at home-style meals and determine their effects on FI, satiety, PPG, and insulin, over three hours. Meals will be served with a fixed amount of beef or vegetarian substitute "meat" balls providing 25 g protein with ad libitum access to one of mashed potatoes, fried French fries, or pasta.

Objective 2: To determine the effect of at home-style meals with beef or a vegetarian substitute with mashed potatoes on FI compensation at an ad libitum pizza meal 3h later. Post-meal PPG and satiety will be measured for one hour.

Objective 3: To compare the amino acid response for 3 h after the meat and vegetarian based meals served with mashed potatoes, French fries, or pasta.

02

Conditions studied

  • Glycemic Control
  • Satiety Response
  • Appetite Regulation
  • Diabetes
  • Obesity

Keywords

  • Glycemic Control
  • Satiety
  • Appetite
  • Potato
  • Protein quality
  • Blood glucose
  • Insulin
  • Ghrelin
  • Nutrition
03

In context

Lead sponsor

University of Toronto is the lead sponsor of 397 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • > 18 and \< 45 years of age
  • BMI > 18.5 and \< 24.9 kg/m2
  • Willing to maintain habitual diet, physical activity pattern, and body weight throughout the study.
  • Willing to maintain current dietary supplement use throughout the study. On test days, subject agrees not to take any dietary supplements until dismissal from the Nutrition Intervention Center. Failure to comply will result in a rescheduled test visit.
  • Willing to abstain from alcohol consumption for 24h prior to all test visits.
  • Willing to refrain from marijuana/ edibles use for the duration of the study (approximately 6 weeks).
  • Willing to avoid vigorous physical activity for 24h prior to all test visits.
  • Understanding the study procedure and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.

Exclusion criteria

Exclusion Criteria:

  • Smoking
  • Thyroid problems
  • Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, a malabsorptive syndrome, pancreatitis, gallbladder or biliary disease.
  • Presence of a gastrointestinal disorder or surgeries within the past year.
  • Known to be pregnant or lactating.
  • Unwillingness or inability to comply with the experimental procedures and to follow our safety guidelines.
  • Known intolerances, sensitivity or allergy to any ingredients in the study products.
  • Extreme dietary habits (i.e Atkins diet, very high protein diets, etc.) or restrained eaters, identified by a score of ≥ 11 on the Eating Habits Questionnaire
  • Uncontrolled hypertension (systolic blood pressure > 140 mm Hg or diastolic blood pressure > 90 mm Hg) as defined by the average blood pressure measured at screening.
  • Weight gain or loss of at least 10lbs in previous three months.
  • Excessive alcohol intake (more than 2 drinks per day or more than 9 drinks per week).
  • Consuming prescription or non-prescription drug, herbal or nutritional supplements known to affect blood glucose or that could affect the outcome of the study as per investigator's judgment.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Ad libitum full-fat French fries with beef meatballs

    Ad libitum carbohydrate side with fixed amount of protein: Ad libitum full-fat French fries with beef meatballs (25 g protein)

    Other: Ad libitum full-fat French fries with beef meatballs

  • Experimental
    Ad libitum instant mashed potatoes with beef meatballs

    Ad libitum carbohydrate side with fixed amount of protein: Ad libitum instant mashed potatoes with beef meatballs (25 g protein)

    Other: Ad libitum instant mashed potatoes with beef meatballs

  • Experimental
    Ad libitum macaroni pasta with beef meatballs

    Ad libitum carbohydrate side with fixed amount of protein: Ad libitum macaroni pasta with beef meatballs (25 g protein)

    Other: Ad libitum macaroni pasta with beef meatballs

  • Experimental
    Ad libitum full-fat French fries with vegetarian substitute meatballs

    Ad libitum carbohydrate side with fixed amount of protein: Ad libitum full-fat French fries with vegetarian substitute meatballs (25 g protein)

    Other: Ad libitum full-fat French fries with vegetarian substitute meatballs

  • Experimental
    Ad libitum instant mashed potatoes with vegetarian substitute meatballs

    Ad libitum carbohydrate side with fixed amount of protein: Ad libitum instant mashed potatoes with vegetarian substitute meatballs (25 g protein)

    Other: Ad libitum instant mashed potatoes with vegetarian substitute meatballs

  • Experimental
    Ad libitum macaroni pasta with vegetarian substitute meatballs

    Ad libitum carbohydrate side with fixed amount of protein: Ad libitum macaroni pasta with vegetarian substitute meatballs (25 g protein)

    Other: Ad libitum macaroni pasta with vegetarian substitute meatballs

Interventions

  • OtherAd libitum full-fat French fries with beef meatballs

    Participants will consume 1 of the 6 treatment meals at each of the 6 study sessions in random orders such that by the end of the study, they will have consumed all 6 treatments. Participants will be given 30 minutes to consume the treatment meal and will be instructed to eat all the meatballs but to eat the French fries ad libitum (250 g), until comfortably full, simulating "at home" meal consumption. After providing the participants with the first plate of 250 g French fries and about 120 g meatballs (25 g protein), additional plates of freshly cooked French fries (250 g) alone will be provided 10 and 20 min later and they will be given 30 min to complete the treatment meal. Each treatment will be served with water.

  • OtherAd libitum instant mashed potatoes with beef meatballs

    Participants will consume 1 of the 6 treatment meals at each of the 6 study sessions in random orders such that by the end of the study, they will have consumed all 6 treatments. Participants will be given 30 minutes to consume the treatment meal and will be instructed to eat all the meatballs but to eat the mashed potatoes ad libitum (250 g), until comfortably full, simulating "at home" meal consumption. After providing the participants with the first plate of 250 g mashed potatoes and about 120 g meatballs (25 g protein), additional plates of freshly cooked mashed potatoes (250 g) alone will be provided 10 and 20 min later and they will be given 30 min to complete the treatment meal. Each treatment will be served with water.

  • OtherAd libitum macaroni pasta with beef meatballs

    Participants will consume 1 of the 6 treatment meals at each of the 6 study sessions in random orders such that by the end of the study, they will have consumed all 6 treatments. Participants will be given 30 minutes to consume the treatment meal and will be instructed to eat all the meatballs but to eat the macaroni pasta ad libitum (250 g), until comfortably full, simulating "at home" meal consumption. After providing the participants with the first plate of 250 g macaroni pasta and about 120 g meatballs (25 g protein), additional plates of freshly cooked macaroni pasta (250 g) alone will be provided 10 and 20 min later and they will be given 30 min to complete the treatment meal. Each treatment will be served with water.

  • OtherAd libitum full-fat French fries with vegetarian substitute meatballs

    Participants will consume 1 of the 6 treatment meals at each of the 6 study sessions in random orders such that by the end of the study, they will have consumed all 6 treatments. Participants will be given 30 minutes to consume the treatment meal and will be instructed to eat all the meatballs but to eat the French fries ad libitum (250 g), until comfortably full, simulating "at home" meal consumption. After providing the participants with the first plate of 250 g French fries and about 120 g vegetarian "meatballs" (25 g protein), additional plates of freshly cooked French fries (250 g) alone will be provided 10 and 20 min later and they will be given 30 min to complete the treatment meal. Each treatment will be served with water.

  • OtherAd libitum instant mashed potatoes with vegetarian substitute meatballs

    Participants will consume 1 of the 6 treatment meals at each of the 6 study sessions in random orders such that by the end of the study, they will have consumed all 6 treatments. Participants will be given 30 minutes to consume the treatment meal and will be instructed to eat all the meatballs but to eat the mashed potatoes ad libitum (250 g), until comfortably full, simulating "at home" meal consumption. After providing the participants with the first plate of 250 g mashed potatoes and about 120 g vegetarian "meatballs" (25 g protein), additional plates of freshly cooked mashed potatoes (250 g) alone will be provided 10 and 20 min later and they will be given 30 min to complete the treatment meal. Each treatment will be served with water.

  • OtherAd libitum macaroni pasta with vegetarian substitute meatballs

    Participants will consume 1 of the 6 treatment meals at each of the 6 study sessions in random orders such that by the end of the study, they will have consumed all 6 treatments. Participants will be given 30 minutes to consume the treatment meal and will be instructed to eat all the vegetarian meatballs but to eat the macaroni pasta ad libitum (250 g), until comfortably full, simulating "at home" meal consumption. After providing the participants with the first plate of 250 g macaroni pasta and about 120 g meatballs (25 g protein), additional plates of freshly cooked macaroni pasta (250 g) alone will be provided 10 and 20 min later and they will be given 30 min to complete the treatment meal. Each treatment will be served with water.

06

What researchers measure

Primary outcomes

  1. Change in Blood Glucose Levels

    Blood glucose level (mmol/L) is measured using finger prick capillary blood samples or intravenous blood samples.

    Time frame: Starting at the beginning of each session (0 minutes before consumption of treatment meal) and every 15-30 minutes up to 180 - 240 minutes (time of completion of each session).

  2. Food Intake

    Food intake at the treatment meal time will be measured by weighing the carbohydrates (CHO) sides plates after the assigned meal time.

    Time frame: After 30 minutes of the treatment meal start.

Secondary outcomes

  1. Change in Insulin Levels

    Level of blood insulin (μU/mL) is measured using finger prick capillary blood samples or intravenous blood samples.

    Time frame: Starting at the beginning of each session (0 minutes before consumption of treatment meal) and every 30 minutes up to 180 - 240 minutes (time of completion of each session).

  2. Change in Active Ghrelin Levels

    Active ghrelin hormone concentrations (μmol/L) is analyzed in intravenous blood samples.

    Time frame: Starting at the beginning of each session (0 minutes before consumption of treatment meal) and every 30 minutes up to 180 - 240 minutes (time of completion of each session).

  3. Change in Amino Acid Response (Protein quality)

    Amino acid concentrations (μmol/L) is analyzed in intravenous blood samples to determine amino acid release.

    Time frame: Starting at the beginning of each session (0 minutes before consumption of treatment meal) and every 30 minutes up to 180 - 240 minutes (time of completion of each session).

  4. Food Intake Compensation

    The food intake compensation after the second meal (ad libitum pizza meal) will be measured (g).

    Time frame: at 180 minutes after the treatment meals.

  5. Change in Subjective Appetite

    Motivation to Eat Adaptive Visual Analogue Scales measured based on a score between 0 to 100. A higher score indicates higher outcome.

    Time frame: up to 180 - 240 minutes (time of completion of each session)

  6. Change in Physical comfort

    Physical Comfort Visual Analogue Scales measured based on a score between 0 to 100. A higher score indicates higher outcome.

    Time frame: up to 180 - 240 minutes (time of completion of each session)

  7. Change in Energy Level

    Energy Level Visual Analogue Scales measured based on a score between 0 to 100. A higher score indicates higher outcome.

    Time frame: up to 180 - 240 minutes (time of completion of each session)

  8. Treatment palatability

    Treatment Palatability Visual Analogue Scales measured based on a score between 0 to 100. A higher score indicates higher outcome.

    Time frame: Immediately after treatment meal consumption

  9. Change in Fatigue Level

    Fatigue Level Visual Analogue Scales measured based on a score between 0 to 100. A higher score indicates higher outcome.

    Time frame: up to 180 - 240 minutes (time of completion of each session)

07

Study locations

1 of 1 sites recruiting
  • University of Toronto - Department of Nutritional Sciences
    Toronto, Ontario M5S 3E2, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 26, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05610124
Lead sponsor
University of Toronto
Collaborators
Alliance for Potato Research and Education
Responsible party
G. Harvey Anderson (Professor, University of Toronto) — Principal investigator
First posted
Nov 9, 2022
Start date
Feb 1, 2023
Primary completion
Dec 31, 2023 (estimated)
Completion
Apr 30, 2024 (estimated)
Last update
Jun 26, 2023

Study contacts

Amira Amr, PhD
Contact
amira.amr@utoronto.ca
6478645258
Hrvoje Fabek, PhD
Contact
hrvoje.fabek@utoronto.ca
(416) 978-0799
G. Harvey Anderson, PhD
principal investigator · University of Toronto

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion